A new survey conducted by NiceLabel has highlighted the increasing importance of a single, integrated label management system for the pharmaceutical industry. The survey of 100 key decision makers revealed the challenges experienced by ...
Tags: Survey, Pharmaceutical Industry
Global biscuit, chocolate and confectionery firm Pladis signed a preferred supplier agreement with Bosch Packaging Technology at Interpack 2017. Bosch will now serve as one of Pladis’ global preferred suppliers of process and ...
Tags: Bosch Packaging, Packaging
CSafe Global furthers the expansion of their diverse sales team with the addition of John Bullon as director of sales for the UK and Ireland. With a proven track record and over a decade of experience as an international senior sales ...
Pharmaceutical company Merck is planning to build new pharmaceutical packaging facility in Darmstadt, Germany with an investment of more than €50m ($55.7m). The German firm said it intends to complement its pharmaceutical production ...
Can-Fite BioPharma has submitted to the European Medicines Agency (EMA) a protocol design for its Phase III trial and Registration Plan for the Company's lead compound CF101 in the treatment of rheumatoid arthritis following a ...
Tags: Phase III trail, CF101, Can-Fite
BASF has signed a definitive agreement to sell its manufacturing facility for natural fish oils, medium-concentrated omega-3s, and customized bottled fish oil in Brattvåg, Norway, to Marine Ingredients, a manufacturer of marine-based ...
Tags: BASF, natural fish oils, Construction
PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced that the Company will release its fourth quarter and full year 2013 financial results for the period ended December 31, 2013, on Monday, March 3, 2014, after market close. PDL's ...
Tags: Antibodies, Antibody, Biotechnology, Cancer, Healthcare, Investment, Protein
DuPont named AnnaMaria DeSalva vice president of corporate communications. In the newly established role, DeSalva, will be responsible for leading, developing and executing the company's strategic communications and brand management around ...
Tags: DuPont, coating, corporate communications, DeSalva
The market for cartridges to remove particles from liquids will grow to over$5 billion per year by 2019.This is the latest forecast in Cartridge Filters:World Market published by the McIlvaine Company. The pharmaceutical industry will ...
Soligenix, a clinical stage biopharmaceutical company focused on developing products to treat serious inflammatory diseases where there remains an unmet medical need, as well as developing several biodefense vaccines and therapeutics, ...
Tags: Soligenix, NIAID, ThermoVax, Drs.John Carpenter
The novel avian H7N9 influenza virus has caused more than 130 human infections with 43 deaths in China. New research, conducted under the supervision of Kansas State University's Juergen Richt, is showing promise in helping to fight this ...
Tags: Influenza Virus, H7N9, Health, Medicine
Sutro Biopharma, a biopharmaceutical company developing a new generation of protein therapeutics, including next-generation antibody drug conjugates and bispecific antibodies, today announced that it has entered into a collaboration ...
Tags: Bispecific Antibodies, Sutro's Cell-Free Protein Synthesis Technology
Can-Fite BioPharma Ltd. (TASE:CFBI), (NYSE MKT:CANF), a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory and cancer diseases, announced today that its subsidiary OphthaliX Inc. (OTCBB:OPLI) ...
Tags: Can-Fite BioPharma, OphthaliX, placebo-controlled phase III study
Bristol-Myers Squibb has announced a series of related changes within its senior management team. To support its ongoing success as a BioPharma leader, the company is evolving its business model, creating a global integrated commercial ...
Currently, monoclonal antibody agents have been successfully used in the treatment of tumors, cancers and other serious diseases as a heavyweight in the biopharmaceutical industry. In 2009-2012, the market size of monoclonal antibody agents ...